Tobacco smoking within psychiatric inpatient settings: A biospsychosocial perspective

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 7, 2007, Pages 572-580

  Olivier, David ^a   Lubman, Dan I ^b   Fraser, Richard ^a  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Inpatients; Nicotine; Psychiatry; Smoking; Tobacco use

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; FLUPHENAZINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; NEUROLEPTIC AGENT; NICOTINE; NICOTINE PATCH; NICOTINIC RECEPTOR; NORTRIPTYLINE; OLANZAPINE; OXAZEPAM; PLACEBO; PROPRANOLOL; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TIOTIXENE; TRAZODONE; TRIAZOLAM; UNINDEXED DRUG;

ANXIETY DISORDER; AUSTRALIA AND NEW ZEALAND; BEHAVIOR THERAPY; BIPOLAR DISORDER; CIGARETTE SMOKING; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DEPRESSION; DISEASE CONTROL; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENTIATION; DRUG TOLERABILITY; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; MENTAL DISEASE; MENTAL HEALTH RESEARCH; MORBIDITY; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SAFETY; PRACTICE GUIDELINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOEDUCATION; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SMOKING CESSATION PROGRAM; SMOKING HABIT; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; STANDARDIZATION; TOBACCO DEPENDENCE; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DRUG INTERACTIONS; HUMANS; INTERPERSONAL RELATIONS; MENTAL DISORDERS; NICOTINE; PATIENT COMPLIANCE; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHOTROPIC DRUGS; REINFORCEMENT (PSYCHOLOGY); SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 34250616692     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670701392809     Document Type: Review

References (75)

1. Ridolfo, B. and Stevenson, C. (1998) Australian Institute of Health and Welfare, Australian Institute of Health and Welfare, Canberra
2. (2005) Tobacco policy: Using evidence for better outcomes, RACP and RANZCP, Sydney
3. Hughes, JR. (1993) Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J Clin Psychiatry, 54, pp. 109-114.
4. Ziedonis, DM and George, TP. (1997) Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull, 23, pp. 247-254.
5. Prochaska, JJ, Fletcher, L., Hall, SE and Hall, SM. (2006) Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict, 15, pp. 15-22.
6. Lawn, S. and Pols, R. (2003) Nicotine withdrawal: Pathway to aggression and assault in the locked psychiatric ward?. Australas Psychiatry, 11, pp. 199-203.
7. Dickens, G., Stubbs, J., Popham, R. and Haw, C. (2005) Smoking in a forensic psychiatric service: A survey of inpatients' views. J Psychiatr Ment Health Nurs, 12, pp. 672-678.
8. Gritz, ER, Stapleton, JM, Miller, RR and Jaravik, ME. (1985) Prevalence of cigarette smoking in VA medical and psychiatric hospitals. Bull Soc Psychol Addict Behav, 4, pp. 151-165.
9. McDonald, CA, Robert, S. and Descheemaeker, N. (2000) Intentions to quit smoking in substance-abusing teens exposed to a tobacco program. J Subst Abuse Treat, 18, pp. 291-308.
10. Fowles, J., Bates, M. and Noiton, D. (2000) Chemical constituents in cigarettes and cigarette smoke: Priorities for harm reduction. A report to the Ministry of Health, ESR, Porirua, New Zealand
11. (1989) Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General
12. Brown, S., Inskip, H. and Barraclough, B. (2000) Causes of the excess mortality of schizophrenia. Br J Psychiatry, 177, pp. 212-217.
13. Colton, CW and Manderscheid, RW Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis
14. Pontieri, FE, Tanda, G., Orzi, F. and DiChiara, G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382, pp. 255-257.
15. Clarke, PB. (1990) Mesolimbic dopamine activation: The key to nicotine reinforcement?. Ciba Found Symp, 152, pp. 153-162.
16. Leonard, S., Breese, C. and Adams, C. (2000) Smoking and schizophrenia: abnormal nicotinic receptor expression. Eur J Pharmacol, 393, pp. 237-242.
17. Patkar, AA, Gopalakrishnan, R., Lundy, A., Leone, FT, Certa, KM and Weinstein, SP. (2002) Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis, 190, pp. 604-610.
18. Quattrocki, E., Baird, A. and Yurgelun-Todd, X. (2000) Biological aspects of the link between smoking and depression. Harv Rev Psychiatry, 8, pp. 99-110.
19. Fowler, JS, Volkow, ND and Wang, GJ (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature, 379, pp. 733-736.
20. (2000) Diagnostic and statistical manual of mental disorders, American Psychiatric Association, Washington, DC
21. Desai, HD, Seabolt, J. and Jann, MW. (2001) Smoking in patients receiving psychotropic medications. A pharmacokinetic perspective. CNS Drugs, 15, pp. 469-494.
22. Tantcheva-Poor, I., Zaigler, M., Rietbrock, S. and Fuhr, U. (1999) Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics, 9, pp. 131-144.
23. Van Der Weide, J., Steijns, LS and Van Weelden, MJ. (2003) The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics, 13, pp. 169-172.
24. Miller, LG. (1989) Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet, 17, pp. 90-108.
25. Greenwood-Smith, C., Lubman, DI and Castle, DJ. (2003) Serum clozapine levels: A review of their clinical utility. J Psychopharmacol., 17, pp. 234-238.
26. Zullino, DF, Delessert, D., Eap, CB, Preisig, M. and Baumann, P. (2002) Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol, 17, pp. 141-143.
27. Faber, MS and Fuhr, U. (2004) Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther, 76, pp. 178-184.
28. Lasser, K., Boyd, JW, Woolhandler, S., Himmelstein, DU, McCormick, D. and Bor, DH. (2000) Smoking in mental illness: A population-based prevalence study. JAMA, 284, pp. 2606-2610.
29. Prochaska, JJ, Gill, P. and Hall, SM. (2004) Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv, 55, pp. 1265-1270.
30. Strand, JE and Nyback, H. (2005) Tobacco use in schizophrenia: A study of cotinine concentrations in the saliva of patients and controls. Eur Psychiatry, 20, pp. 50-54.
31. Barnes, M., Lawford, BR and Burton, SC (2006) Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?. Aust N Z J Psychiatry, 40, pp. 575-580.
32. Corvin, A., O'Mahony, E. and O'Regan, M. (2001) Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br J Psychiatry, 179, pp. 35-38.
33. Glassman, AH. (1993) Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry, 150, pp. 546-553.
34. Isensee, B., Wittchen, HU, Stein, MB, Höfler, M. and Lieb, R. (2003) Smoking increases the risk of panic: Findings from a prospective community study. Arch Gen Psychiatry, 60, pp. 692-700.
35. Patton, GC, Hibbert, M., Rosier, MJ, Carlin, JB, Caust, J. and Bowes, G. (1996) Is smoking associated with depression and anxiety in teenagers?. Am J Public Health, 86, pp. 225-230.
36. Ostacher, MJ, Nierenberg, AA and Perlis, RH (2006) The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry, 67, pp. 1907-1911.
37. Peele, R. (1988) Nicotine addiction in the psychiatric hospital: A preliminary report. Psychiatr J Univ Ott, 4, p. 239.
38. Resnick, M. and Bosworth, EE. (1988) A survey of smoking policies in Oregon psychiatric facilities. Hosp Community Psychiatry, 39, pp. 313-315.
39. Keizer, I. and Eytan, A. (2005) Variations in smoking during hopitalization in psychiatric in-patient units and smoking prevalence in patients and health-care staff. Int J Soc Psychiatry, 51, pp. 317-328.
40. Lawrie, SM, Buckley, LA and Ulyatt, BC (1995) Cigarette smoking in psychiatric inpatients. J R Soc Med, 88, p. 59.
41. Strasser, K., Moeller-Saxone, K., Meadows, G., Hocking, B., Stanton, J. and Kee, P. (2002) Smoking cessation in schizophrenia. General practice guidelines. Aust Fam Physician, 31, pp. 21-24.
42. Chabrol, H., Faury, R., Mullet, E., Callahan, S., Weigelt, A. and Labrousse, F. (2002) Study of nicotine dependence among 342 adolescents smokers. Arch Pediatr, 7, pp. 1064-1071.
43. Mester, R., Toren, P., Ben-Moshe, Y. and Weizman, A. (1993) Survey of smoking habits and attitudes of patients and staff in psychiatric hospitals. Psychopathology, 26, pp. 69-75.
44. Addington, J., El-Guebaly, N., Addington, D. and Hodgins, D. (1997) Readiness to stop smoking in schizophrenia. Can J Psychiatry, 42, pp. 49-52.
45. Velicer, WF, Fava, JL, Prochaska, JO, Abrams, DB, Emmons, KM and Pierce, JP. (1995) Distribution of smokers by stage in three representative samples. Prev Med, 24, pp. 401-411.
46. Carosella, AM, Ossip-Klein, DJ and Owens, CA. (1999) Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav, 24, pp. 331-344.
47. Irving, LM, Seidner, AL, Burling, TA, Thomas, RG and Brenner, GF. (1994) Drug and alcohol abuse inpatients' attitude about smoking cessation. J Subst Abuse, 6, pp. 267-278.
48. Saxon, AJ, McGuffin, R. and Walker, RD. (1997) An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol- and drug-dependent inpatients. J Subst Abuse Treat, 14, pp. 333-337.
49. Dore, K. and Hoey, J. (1988) Smoking practices: Knowledge and attitudes regarding smoking of university hospital nurses. Can J Public Health, 79, pp. 170-174.
50. Tagliacozzo, R. and Vaughan, S. (1982) Stress and smoking in hospital nurses. Am J Public Health, 5, pp. 441-448.
51. Dickens, GL, Stubbs, JH and Haw, CM. (2004) Smoking and mental health nurses: A survey of clinical staff in a psychiatric hospital. J Psychiatr Ment Health Nurs, 11, pp. 445-451.
52. Buchanan, CR, Huffman, C. and Barbour, VM. (1994) Smoking health risks: counselling of psychiatric patients. J Psychosoc Nurs Ment Health Serv, 32, pp. 27-32.
53. (2006) Practice guidelines for the treatment of patients with substance use disorders
54. D'Mello, DA, Bandlamudi, GR and Colenda, CC. (2001) Nicotine replacement methods on a psychiatric unit. Am J Drug Alcohol Abuse, 27, pp. 525-529.
55. Palmer, KJ, Buckley, MM and Faulds, D. (1992) Transdermal nicotine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs, 44, pp. 498-529.
56. Kornitzer, M., Boutsen, M., Dramaix, M., Thijs, J. and Gustavsson, G. (1995) Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Prev Med, 24, pp. 41-47.
57. Bohadana, A., Nilsson, F., Rasmussen, T. and Martinet, Y. (2000) Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: A randomized, double-blind, placebo controlled trial. Arch Intern Med, 160, pp. 3128-3134.
58. Shiffman, S., Dresler, CM, Hajek, P., Gilburt, SJ, Targett, DA and Strahs, KR. (2002) Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med, 162, pp. 1267-1276.
59. Addington, J., El-Guebaly, N., Campbell, W., Hodgins, DC and Addington, D. (1998) Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry, 155, pp. 974-976.
60. George, TP, Ziedonis, DM and Feingold, A. (2000) Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry, 157, pp. 1835-1842.
61. Hurt, RD, Sachs, DP and Glover, ED (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med, 337, pp. 1195-1202.
62. Hughes, J., Stead, L. and Lancaster, T. (2004) Antidepressants for smoking cessation. Cochrane Database Syst Rev
63. West, R. (2002) Helping patients in hospital to quit smoking. BMJ, 324, p. 64.
64. Rigotti, NA, Munafo, MR, Murphy, MF and Stead, LF (2003) Interventions for smoking cessation in hospitalised patients. Cochrane Database of Syst Rev
65. Taylor, CB, Miller, NH, Cameron, RP, Fagans, EW and Das, S. (2005) Dissemination of an effective inpatient tobacco use cessation program. Nicotine Tob Res, 7, pp. 129-137.
66. Baker, A., Richmond, R. and Haile, M. (2006) A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry, 163, pp. 1934-1942.
67. Washington, A., Moll, S. and Pawlick, J. (1997) Smokebusters: An approach to help people with a mental illness move closer to a smoke-free lifestyle, Community Social and Vocational Rehabilitation Foundation, Hamilton, Ontario
68. Lawn, S. and Pols, R. (2005) Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry, 39, pp. 866-885.
69. El-Guebaly, N., Cathcart, J., Currie, S., Brown, D. and Gloster, S. (2002) Public health and therapeutic aspects of smoking bans in mental health and addiction settings. Psychiatr Serv, 53, pp. 1617-1622.
70. Greeman, M. and McClellan, TA. (1991) Negative effects of a smoking ban on an inpatient psychiatry service. Hosp Community Psychiatry, 42, pp. 408-412.
71. Velasco, J., Eels, TD and Anderson, R. (1996) A two year follow-up on the effects of a smoking ban in an inpatient psychiatric service. Psychiatr Serv, 47, pp. 869-871.
72. Killen, JD, Fortmann, SP, Schatzberg, A., Hayward, C. and Varady, A. (2003) Onset of major depression during treatment for nicotine dependence. Addict Behav, 28, pp. 461-470.
73. McNeill, A. (2001) Smoking and mental health: A review of the literature. Report for SmokeFree London programme, SmokeFree London Programme, London
74. Lavin, M. (1990) Let the patients smoke: A defence of a patient privilege. J Med Ethics, 16, pp. 136-140.
75. Bloch, M. and Shopland, DR. (2000) Outdoor smoking bans: More than meets the eye. Tobacco Control, 9, p. 99.